Genetic Determinants of Response to Warfarin in Thai Patients
Background: Genetic variants of the enzyme that metabolizes warfarin, cytochrome P 450 2C9 (CYP2C9), and of a key pharmacologic target of warfarin, vitamin K epoxide reductase (VKORC1), contribute to differences in patients’ responses to various warfarin doses, but the role of these variants in Thai...
Saved in:
Main Authors: | Parichat Sittinateskul, Pantep Angchaisuksiri, Werasak Sasanakul, Ampaiwan Chuansumrit, ปริฉัตร์ สิทธิเนตรสกุล, พันธ์ุเทพ อังชัยสุขศิริ, วีระศักดิ์ ศาสนกุล, อำไพวรรณ จวนสัมฤทธิ์ |
---|---|
Other Authors: | Mahidol University. Faculty of Medicine Ramathibodi Hospital. Department of Medicine |
Format: | Original Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/79903 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Language: | English |
Similar Items
-
Pharmacogenetics of Warfarin Should we test?
by: Pantep Angchaisuksiri, et al.
Published: (2022) -
Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: A randomized controlled trial
by: Syn N.L., et al.
Published: (2019) -
Renal handling of warfarin metabolites in man
by: Chan, E., et al.
Published: (2014) -
In vivo aspects of potential stereospecific drug interactions of oral warfarin and rutin in rats
by: AKHIL KUMAR HEGDE R
Published: (2011) -
Effect of ubidecarenone on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats
by: Zhou, S., et al.
Published: (2014)